CICERI, SAMUELE
CICERI, SAMUELE
Dipartimento di Scienze Farmaceutiche
SYNTHESIS OF PHARMACOLOGICALLY ACTIVE MOLECULES THROUGH BIOCATALYTIC APPROACHES: STUDY OF THEIR STEREOCHEMISTRY AND POLYMORPHISM BY MEANS OF SPECTROSCOPIC AND CRYSTALLOGRAPHIC METHODS.
2024 S. Ciceri
A new class of GnRH receptor modulators endowed with atropisomerism
2023 S. Ciceri, D. Colombo, E.M.A. Fassi, P. Ferraboschi, G. Grazioso, P. Grisenti, F. Meneghetti
Insights on the atropisomeric properties of elagolix and its derivatives
2023 S. Ciceri, D. Colombo, E.M.A. Fassi, P. Ferraboschi, G. Grazioso, P. Grisenti, F. Meneghetti
Elagolix and its derivatives: Analytical and theoretical investigations of their atropisomeric properties
2023 S. Ciceri
Elagolix Sodium Salt and Its Synthetic Intermediates: A Spectroscopic, Crystallographic, and Conformational Study
2023 S. Ciceri, D.R. Colombo, E.M.A. Fassi, P. Ferraboschi, G. Grazioso, P. Grisenti, M. Iannone, C. Castellano, F. Meneghetti
Heat-Treated Lysozyme Hydrochloride: A Study on Its Structural Modifications and Anti-SARS-CoV-2 Activity
2023 S. Delbue, E. Pariani, S. Parapini, C. Galli, N. Basilico, S. D’Alessandro, S. Pellegrino, E. Pini, S. Ciceri, P. Ferraboschi, P. Grisenti
Physiological and Pharmacological overview of the Gonadotropin Releasing Hormone
2023 L. Casati, S. Ciceri, R. Maggi, D. Bottai
Elagolix analogues as potential new GnRH antagonists
2022 S. Ciceri, D. Colombo, E. Fassi, P. Ferraboschi, G. Grazioso, P. Grisenti, F. Meneghetti
Elagolix analogues as potential new GnRH antagonists: design, synthesis and characterization
2022 S. Ciceri, D. Colombo, E. Fassi, P. Ferraboschi, G. Grazioso, P. Grisenti, F. Meneghetti
Virtual screening and crystallographic studies reveal an unexpected γ-lactone derivative active against MptpB as a potential antitubercular agent
2022 G. Cazzaniga, M. Mori, F. Meneghetti, L.R. Chiarelli, G. Stelitano, I. Caligiuri, F. Rizzolio, S. Ciceri, G. Poli, D. Staver, G. Ortore, T. Tuccinardi, S. Villa
Synthesis and automated fluorine‐18 radiolabeling of new PSMA‐617 derivatives with a CuAAC radiosynthetic approach
2022 M.N. Iannone, S. Stucchi, E.A. Turolla, C. Beretta, S. Ciceri, C. Chinello, L. Pagani, S. Todde, P. Ferraboschi
Design, synthesis, characterization, and biological activity of new derivatives of elagolix, a potent GnRH antagonist
2021 S. Ciceri, D.R. Colombo, P. Ferraboschi, P. Grisenti, S.V. Sforna, F. Meneghetti
Low-Molecular-Weight Phosphatase B (LMW-MPtpB) inhibition as a strategy to identify new drug candidates against tuberculosis
2021 M. Mori, G. Cazzaniga, L.R. Chiarelli, G. Stelitano, S. Ciceri, T. Tuccinardi, G. Poli, F. Meneghetti, S. Villa
An Outline of the Latest Crystallographic Studies on Inhibitor-Enzyme Complexes for the Design and Development of New Therapeutics against Tuberculosis
2021 M. Mori, S. Villa, S. Ciceri, D.R. Colombo, P. Ferraboschi, F. Meneghetti
Applications of Lysozyme, an Innate Immune Defense Factor, as an Alternative Antibiotic
2021 P. Ferraboschi, S. Ciceri, P. Grisenti
Vecuronium bromide and its advanced intermediates : a crystallographic and spectroscopic study
2021 S. Ciceri, D. Colombo, P. Ferraboschi, P. Grisenti, M. Iannone, M. Mori, F. Meneghetti
Biocatalytic synthesis of two pharmacologically active compounds: (S)-pramipexole and its enantiomer, dexpramipexole.
2020 S. Ciceri, P. Ferraboschi, P. Grisenti, M. Mori, F. Meneghetti
The sad story of an anzymatic reaction in the fridge
2020 S. Ciceri, D. Colombo, F. Compostella, S. Reza Elahi, P. Ferraboschi
Biocatalysts for the synthesis of pharmacologically active compounds
2020 S. Ciceri, P. Grisenti, F. Meneghetti, M. Mori, S. Reza Elahi, P. Ferraboschi
Crystallographic and NMR Investigation of Ergometrine and Methylergometrine, Two Alkaloids from Claviceps purpurea
2020 F. Meneghetti, P. Ferraboschi, P. Grisenti, S. Reza Elahi, M. Mori, S. Ciceri